Szabó Bálint Gergely, Kiss Rebeka, Lénárt Katalin Szidónia, Radka Nikolova, Kádár Béla
Országos Hematológiai és Infektológiai Intézet, Infektológiai Osztály, Dél-pesti Centrumkórház Budapest, Albert Flórián út 5-7., 1097.
Klinikai Orvostudományok Doktori Iskola, Semmelweis Egyetem Budapest.
Orv Hetil. 2019 Dec;160(48):1887-1893. doi: 10.1556/650.2019.31597.
Streptococcal toxic shock syndrome (STSS) is a hyperacute, life-threatening illness, a complication of invasive streptococcal (mostly group A, rarely groups B, G or C) infection. There is no portal of entry (skin, vagina, pharynx) in nearly half of the STSS cases. The initial signs and symptoms (fever, flu-like complaints, hypotension) are scarce and aspecific, but because of its rapid progression and poor prognosis, early high level of suspicion is necessary. Management has 3 crucial points: initiation of anti-streptococcal regimen (and intravenous immunoglobulin in some cases), aggressive intensive care support of multi-organ failure, and surgical control of the infective source. In this article, we present a case of a patient succumbing to streptococcal toxic shock syndrome which was preceded by primary bacteremia, and review the key points of this potentially fatal disease for practising clinicians. Orv Hetil. 2019; 160(48): 1887-1893.